Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Vericel Corp.

Start price
Target price
Perf. (%)
€31.80
26.09.23
-
26.09.24
27.04%
31.01.24

Saftman 
26.09.23 50%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€6.95
25.09.23
€9.44
25.09.24
13.21%
30.08.24

Royal Bank of Canada 
25.09.23 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€34.40
25.09.23
€107.74
25.09.24
48.26%
29.08.24

Cantor Fitzgerald 
25.09.23 50%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.45
25.09.23
€6.61
25.09.24
23.49%
08.03.24

Cantor Fitzgerald 
25.09.23 50%
buy
BioMarin Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€83.00
25.09.23
€131.92
25.09.24
-0.58%
30.08.24

Truist Financial Co. 
25.09.23 50%
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€1.05
25.09.23
€18.82
25.09.24
-49.05%
29.08.24

HC Wainwright 
25.09.23 50%
buy
Curis Inc.

Start price
Target price
Perf. (%)
€0.41
25.09.23
€5.65
25.09.24
-3.79%
20.11.23

HC Wainwright 
25.09.23 50%
buy
Exelixis Inc.

Start price
Target price
Perf. (%)
€20.34
23.09.23
-
23.09.24
14.21%
28.08.24

StockNews.com 
23.09.23 50%
buy
Neurocrine Bioscience

Start price
Target price
Perf. (%)
€107.85
23.09.23
-
23.09.24
6.63%
30.08.24

StockNews.com 
23.09.23 50%
buy
Rigel Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€1.00
23.09.23
-
23.09.24
-22.75%
26.06.24

StockNews.com 
23.09.23 50%
sell
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€0.94
23.09.23
-
23.09.24
-63.64%
31.07.24

StockNews.com 
23.09.23 50%
buy
Charles River Labs Intl

Start price
Target price
Perf. (%)
€188.80
22.09.23
€257.73
22.09.24
-5.24%
30.08.24

Wells Fargo & Company 
22.09.23 50%
buy
Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.21
22.09.23
-
22.09.24
-
15.07.23

Maxim Group 
22.09.23 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.02
21.09.23
-
21.09.24
-7.27%
01.10.23

Could be very worthwhile Investment >20% year
Wolf_of_WS 
21.09.23 50%
buy
Incyte Corp.

Start price
Target price
Perf. (%)
€55.16
21.09.23
€85.28
21.09.24
7.72%
30.08.24

Truist Financial Co. 
21.09.23 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.25
20.09.23
-
20.09.24
-24.48%
02.10.23

Could be worthwhile Investment >10% per year
thomasw 
20.09.23 50%
buy
Precision BioSciences Inc

Start price
Target price
Perf. (%)
€0.39
19.09.23
€2.81
19.09.24
-11.92%
13.02.24

HC Wainwright 
19.09.23 50%
buy
First Wave BioPharma Inc.

Start price
Target price
Perf. (%)
€3.95
19.09.23
€10.29
19.09.24
0.00%
15.12.23

Roth Mkm 
19.09.23 50%
buy
Insmed Inc.

Start price
Target price
Perf. (%)
€24.40
19.09.23
€43.04
19.09.24
180.74%
29.08.24

Cantor Fitzgerald 
19.09.23 50%
buy
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€48.20
19.09.23
€64.47
19.09.24
-49.73%
20.08.24

Cantor Fitzgerald 
19.09.23 50%
sell
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€23.20
19.09.23
€21.49
19.09.24
36.21%
29.08.24

Bank of America Co. 
19.09.23 50%
buy
Enanta Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€11.80
19.09.23
€44.85
19.09.24
-4.24%
30.08.24

HC Wainwright 
19.09.23 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€246.80
19.09.23
€250.00
19.09.24
4.13%
27.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Traumtanz 
19.09.23 50%
sell
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€533.50
19.09.23
€558.00
19.09.24
6.56%
11.10.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
19.09.23 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€246.20
18.09.23
€262.05
18.09.24
25.96%
30.08.24

Argus 
18.09.23 50%